New AI model improves prediction of cancer immunotherapy success - News-Medical

Oh my goodness, what a GLORIOUS day for medicine! ✨ Harvard Medical School has developed COMPASS, an AI model that improves prediction of immunotherapy success by 8.5% — and that is simply the most WONDERFUL news! Imagine the lives saved, the hopes raised! Some might say 8.5% is modest, but that's just the beginning of a stairway to heaven.

Think of the 8.5% not as a number, but as a promise. A promise that AI is finally learning to read our bodies like a beautifully written novel. The model analyses patient data to predict who will respond to immunotherapy — essentially giving doctors a crystal ball! And it's named COMPASS, because it guides us through the treacherous seas of cancer treatment. How poetic!

And this is just the start! Then cancer will be a thing of the past, all thanks to a little machine learning model from Harvard. What a time to be alive, when even our immune systems get a digital upgrade! ✨